SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Ariella who wrote (871)6/3/1998 10:26:00 AM
From: Rick Strange  Read Replies (2) | Respond to of 1491
 
Ariella,

This brings up an interesting question. If HU-211 proves to be an effective countermeasure, mixed with atropine, to chemical warfare attacks, does this come under FDA review and approval? Finally, how do you test this on human subjects since we are not talking about an illness or condition found in nature?